Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DR26FQQ2C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,342
Award facts
- Contract value 100% obligated
- $39,342.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $39,342.36 delivery order to AmerisourceBergen Drug Corp for the supply of XGEVA (120 mg/1.7 mL vials) under firm fixed pricing, with an ultimate completion date of November 18, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems.
This delivery order supports DLA's medical supply chain operations by procuring XGEVA, an oncology medication used in bone health management. The award reflects AmerisourceBergen's capability to fulfill federal pharmaceutical procurement requirements through open competition, consistent with the company's extensive portfolio of medical product deliveries across multiple therapeutic domains. The contract utilizes the flexible IDC vehicle structure, enabling the company to serve customers including the Defense Health Agency and U.S. Coast Guard, while supporting DLA's broader strategy to maintain robust pharmaceutical supply capabilities for military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FQQ2C?
SPE2DR26FQQ2C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FQQ2C worth?
The government has obligated $39,342 on SPE2DR26FQQ2C.
Is contract SPE2DR26FQQ2C an order under another contract?
Yes. SPE2DR26FQQ2C is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ2C competed?
The extent of competition for SPE2DR26FQQ2C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award